Granulocyte colony-stimulating factors (G-CSF) is an effective treatment for neutropenia but was reported to have a correlation with higher incidences of acute myeloid leukemia and myelodysplastic syndrome [5,6]. The gene discussed is CSF3; the disease is neutropenia.